207 related articles for article (PubMed ID: 8101078)
1. Anti-oxidant properties of H2-receptor antagonists. Effects on myeloperoxidase-catalysed reactions and hydroxyl radical generation in a ferrous-hydrogen peroxide system.
van Zyl JM; Kriegler A; van der Walt BJ
Biochem Pharmacol; 1993 Jun; 45(12):2389-97. PubMed ID: 8101078
[TBL] [Abstract][Full Text] [Related]
2. Effects of H2-receptor antagonists on gastric alcohol dehydrogenase activity.
Caballería J; Baraona E; Deulofeu R; Hernández-Muñoz R; Rodés J; Lieber CS
Dig Dis Sci; 1991 Dec; 36(12):1673-9. PubMed ID: 1684149
[TBL] [Abstract][Full Text] [Related]
3. Cimetidine and other H2 receptor antagonists as powerful hydroxyl radical scavengers.
Ching TL; Haenen GR; Bast A
Chem Biol Interact; 1993 Feb; 86(2):119-27. PubMed ID: 8095439
[TBL] [Abstract][Full Text] [Related]
4. [Effects of various histamine H2-receptor antagonists on gastrointestinal motility and gastric emptying].
Ohira Y; Hanyu N; Aoki T; Hashimoto Y; Iikura M; Fukuda S
J Smooth Muscle Res; 1993 Aug; 29(4):131-42. PubMed ID: 7907895
[TBL] [Abstract][Full Text] [Related]
5. Comparative study of the H2-receptor antagonists cimetidine, ranitidine, famotidine and nizatidine on the rabbit stomach fundus and sigmoid colon.
Kounenis G; Koutsoviti-Papadopoulou M; Elezoglou A; Voutsas A
J Pharmacobiodyn; 1992 Oct; 15(10):561-5. PubMed ID: 1362967
[TBL] [Abstract][Full Text] [Related]
6. The effects of cimetidine, ranitidine, and famotidine on human neutrophil functions.
Mikawa K; Akamatsu H; Nishina K; Shiga M; Maekawa N; Obara H; Niwa Y
Anesth Analg; 1999 Jul; 89(1):218-24. PubMed ID: 10389808
[TBL] [Abstract][Full Text] [Related]
7. Hepatoprotective, antinociceptive and antioxidant activities of cimetidine, ranitidine and famotidine as histamine H2 receptor antagonists.
Ahmadi A; Ebrahimzadeh MA; Ahmad-Ashrafi S; Karami M; Mahdavi MR; Saravi SS
Fundam Clin Pharmacol; 2011 Feb; 25(1):72-9. PubMed ID: 20070855
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms by which clofazimine and dapsone inhibit the myeloperoxidase system. A possible correlation with their anti-inflammatory properties.
van Zyl JM; Basson K; Kriegler A; van der Walt BJ
Biochem Pharmacol; 1991 Jul; 42(3):599-608. PubMed ID: 1650217
[TBL] [Abstract][Full Text] [Related]
9. Structural characteristics of histamine H2 receptor antagonists that scavenge hypochlorous acid.
Ching TL; de Jong J; Bast A
Eur J Pharmacol; 1994 Jun; 268(1):89-93. PubMed ID: 7925615
[TBL] [Abstract][Full Text] [Related]
10. Tolerance during 29 days of conventional dosing with cimetidine, nizatidine, famotidine or ranitidine.
Nwokolo CU; Smith JT; Gavey C; Sawyerr A; Pounder RE
Aliment Pharmacol Ther; 1990; 4 Suppl 1():29-45. PubMed ID: 1983345
[TBL] [Abstract][Full Text] [Related]
11. H2-receptor antagonists are scavengers of oxygen radicals.
Lapenna D; De Gioia S; Mezzetti A; Grossi L; Festi D; Marzio L; Cuccurullo F
Eur J Clin Invest; 1994 Jul; 24(7):476-81. PubMed ID: 7957505
[TBL] [Abstract][Full Text] [Related]
12. Drug interactions of H2-receptor antagonists.
Bachmann KA; Sullivan TJ; Jauregui L; Reese J; Miller K; Levine L
Scand J Gastroenterol Suppl; 1994; 206():14-9. PubMed ID: 7863246
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the effects of antioxidant non-steroidal anti-inflammatory drugs against myeloperoxidase and hypochlorous acid luminol-enhanced chemiluminescence.
Pekoe G; Van Dyke K; Mengoli H; Peden D; English D
Agents Actions; 1982 Apr; 12(1-2):232-8. PubMed ID: 6282074
[TBL] [Abstract][Full Text] [Related]
14. Bismuth increases hydroxyl radical-scavenging activity of histamine H2-receptor antagonists.
Kirkova M; Alexandrova A; Yordanova N
Pharmacol Rep; 2006; 58(2):215-20. PubMed ID: 16702623
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetic and pharmacodynamic properties of histamine H2-receptor antagonists. Relationship between intrinsic potency and effective plasma concentrations.
Lin JH
Clin Pharmacokinet; 1991 Mar; 20(3):218-36. PubMed ID: 1673880
[TBL] [Abstract][Full Text] [Related]
16. Effects of histamine H(2)-receptor antagonists on human plasma levels of calcitonin gene-related peptide, substance P and vasoactive intestinal peptide.
Itoh H; Naito T; Takeyama M
J Pharm Pharmacol; 2002 Nov; 54(11):1559-63. PubMed ID: 12495560
[TBL] [Abstract][Full Text] [Related]
17. H2-antagonists and alcohol. Do they interact?
Gugler R
Drug Saf; 1994 Apr; 10(4):271-80. PubMed ID: 7912509
[TBL] [Abstract][Full Text] [Related]
18. A comparison of the cholinergic activity of selected H2-antagonists and sulfoxide metabolites.
Kosh JW; Sowell JW; Chapman JM
Pharm Res; 1989 Aug; 6(8):709-13. PubMed ID: 2573049
[TBL] [Abstract][Full Text] [Related]
19. [Inhibition of 24-hour acidity by nizatidine].
Dammann HG; Dreyer M; Gottlieb WR; Wolf N; Müller P; Simon B
Fortschr Med; 1989 May; 107(14):321-4. PubMed ID: 2568971
[TBL] [Abstract][Full Text] [Related]
20. Gastroprokinetic activity of nizatidine, a new H2-receptor antagonist, and its possible mechanism of action in dogs and rats.
Ueki S; Seiki M; Yoneta T; Aita H; Chaki K; Hori Y; Morita H; Tagashira E; Itoh Z
J Pharmacol Exp Ther; 1993 Jan; 264(1):152-7. PubMed ID: 8093722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
